1. Abbott, A., Novartis to shut brain research facility. Nature 2011;480:161-162.
2. Stovall, S. R&D cuts curb brain-drug pipeline: development of new medicines for brain disorders could be threatened as major drug makers scale back research. Wall Street Journal; March 27, 2011. Available at:
http://www.wsj.com/articles/SB10001424052748704474804576222463927753954
Accessed February 8, 2017.
3. Heemskerk, J, Farkas, R, Kaufmann, P. Neuroscience networking: linking discovery to drugs. Neuropsychopharmacology 2012;37:287-288.
4. Brown, D., Superti-Furga, G. Rediscovering the sweet spot in drug discovery. Drug Discov Today 2003;8;1067-1077.
5. Funding was continued via a R01 grant and resulted in funding from outside sources and formation of a new company. Available at:
http://www.oricularx.com
. Accessed August 7, 2016.